‘A new National Health Policy needs to be rolled out ’
A high level FICCI delegation led by Sidharth Birla, President, FICCI met the Union Health and Family Welfare Minister Dr Harsh…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Substitute
‘We would be able to play our role in helping India’s pharma exports’
Pharmexcil has come into effect in May 2004. Since then it has been liaising between industry and Government to help promote…
‘One window clearance should be made possible’
Firstly, there has to be a separate documented booklet on schemes announced by the Government till today, specially for the…
‘The funding amount provided should be reasonable to meet requirements’
The best scheme for Technology Upgradation Fund Scheme (TUFS) for SMEs should be the one that identifies their need and meets…
‘Government may consider offering higher depreciation benefits’
Pharma export associations should act as a facilitator in setting up warehouses in Asian, Latin American and African countries by…
‘Urge GoI to take strong steps towards ensuring availability of skilled manpower, electricity,…
SEZ's pain TIL Healthcare has set-up a state-of-the-art facility at an SEZ in 2010 with a focus on export. However, two years down…
‘Industry needs more a predictable IP environment’
It is after a long hiatus that India has got a government at the centre with a clear majority. This is an opportunity that Prime…
‘Less government and more governance will do the magic’
We have been fortunate to work closely with Prime Minister Narendra Modi during his tenure as the Chief Minister of Gujarat,…
‘Pharma manufacturing should be excise free’
If the government wants to make healthcare more affordable then all pharma manufacturing should be excise free like the Baddi…
‘We need to relook at our IPR laws’
The Modi Government should focus on three As of healthcare delivery viz. Availability, Affordability and Access. To achieve this,…
‘Create an ecosystem that encourages innovative R&D in the pharma space’
We believe that a decisive mandate for the Modi Government is definitely a welcome outcome. A decisive mandate will create a…
‘Government should work as a facilitator and not as a regulator’
The Modi governmen should encourage Indian pharma industry to have the slogan "Discover in India" and not "Made in India "…
‘Bulk drug industry needs special financial package’
Indian bulk drug industry has been losing to Chinese competition and our dependence on Chinese APIs has been increasing. It is…
‘Prioritise IP rights, to create a constant cycle of innovation that will help sustain India’s…
PhRMA and its member companies are eager to work with the new government to strengthen the biopharma industry’s relationship with…
‘Main focus should be on developing a mass-based health insurance system’
Five years ago, in the same publication, I wrote about what are healthcare matters and what should be the priorities of the then…
‘Set up fast track courts to address IPR disputes’
The Organisation of Pharmaceutical Producers in India (OPPI), much like the rest of industry has high expectations of the new…
‘New government should get its regulatory role restored’
Over the last three years medical research in India has been brought to standstill. Clinical trials are essential for affordable…
’I value exp erience over qualification’
Learning, of course, need to be a continuous process not only for better earning, but also for quality of life and healthy living.…
’Right blend of qualifications and experience is the need of hour’
Knowledge-driven industry The pharmaceutical science is an applied science and therefore obviously is driven by the enhancements…
’Life should be driven by a passion to learn’
Sharpening one’s axe I think that is absolutely essential. Technology is evolving very rapidly today and it is all the more…